JamesG.ZangrilliMD
Pulmonology • Spring House, PAAsthma & COPD, Critical Care Medicine, Interstitial Lung Diseases, Pleural Disease
Portfolio Clinical Leader, Tremfya
Dr. Zangrilli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Janssen Research and Development LLC
1400 McKean Rd
Spring House, PA 19477
Summary
- Dr. James Zangrilli is a pulmonologist in Philadelphia, PA. He received his medical degree from Sidney Kimmel Medical College and was in active practice through 2015 and continues to work full time in pharmaceutical drug development. He specializes in asthma & copd, critical care medicine, interstitial lung diseases, and pleural disease and is experienced in critical care medicine and general pulmonology.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Pulmonary Disease and Critical Care Medicine, 1991 - 1995- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1988 - 1991
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1988
Certifications & Licensure
PA State Medical License 1992 - 2024
Publications & Presentations
PubMed
- 108 citationsEosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.Liam G Heaney, Luis Pérez de Llano, Mona Al-Ahmad, Vibeke Backer, John Busby
Chest. 2021-04-19 - 89 citationsOnset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asth...Tim W Harrison, Pascal Chanez, Francesco Menzella, Giorgio Walter Canonica, Renaud Louis
The Lancet. Respiratory Medicine. 2021-03-01 - 19 citationsOral Corticosteroid Treatment Patterns of Patients in the United States with Persistent AsthmaTrung N. Tran, Sharon MacLachlan, Wesley Hicks, Jieruo Liu, Yen Chung
The Journal of Allergy and Clinical Immunology. in Practice. 2021-01-01
Journal Articles
- Baseline Patient Factor Impact on the Clinical Efficacy of Benralizumab for Severe AsthmaJames G Zangrilli, Michael E Wechsler, The European Respiratory Journal
Professional Memberships
- Fellow
- Member
Industry Relationships
- Executive Medical Director, AstraZenecaGlobal Medical Affairs, Respiratory Biologics2016 - Present
- Senior Medical Director, TevaRespiratory R&D2013 - 2016
- Medical Director, AstraZenecaRespiratory TA2008 - 2013
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
